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Abstract
Background: Prenatal smoking exposure has been associated with attention-deficit/hyperactivity disorder (ADHD).
ADHD is commonly associated with a wide spectrum of psychiatric comorbidity. The association between smoking and
neuropsychiatric comorbidity of ADHD has remained understudied. The aim of this study is to examine the association
between prenatal exposure to maternal smoking and offspring ADHD, and test whether the smoking-ADHD associations
are stronger when ADHD is accompanied by other lifetime neuropsychiatric comorbidities.
Methods: The study is based on a nested case-control design and includes all Finnish singletons born between 1991 and
2005 and diagnosed with ADHD by 2011 (n = 10,132), matched with four controls (n= 38,811) on date of birth, sex and
residence in Finland.
Results: The risk for ADHD with or without comorbidity was significantly increased among offspring exposed to maternal
smoking on adjusting for potential confounders (OR = 1.75, CI 95 % = 1.65–1.86). Compared to the only ADHD cases,
subjects with comorbid conduct disorder or oppositional defiant disorder had a significantly stronger association with
smoking exposure (OR = 1.80, CI 95 % = 1.55–2.11).
Conclusions: Prenatal smoking represents an important risk factor for the ADHD comorbid with CD/ODD. Further research
on the association between prenatal smoking exposure and neuropsychiatric comorbidity of ADHD is needed
considering the increased risk among these subjects of an overall poor health outcome as compared to only ADHD. In
particular, studies utilizing biomarkers or including subjects with neuropsychiatric conditions with and without comorbid
ADHD are needed.
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Background
Attention-deficit/hyperactivity disorder (ADHD) is esti-
mated to have a worldwide prevalence of 5 % [1]. The
disorder is characterized by impaired attention, hyper-
active and impulsive symptoms with an onset at childhood
[2, 3]. ADHD is commonly associated with a wide
spectrum of psychiatric comorbidity. Among ADHD cases,
comorbid diagnosis of autism spectrum disorders (ASD)
are found in 10–33% [4, 5], conduct disorder (CD) in
16–18% [6, 7], learning and coordination disorders in
15–46% [4, 6, 7] and mental retardation in 4–8% [4, 6].
Both genetic and environmental risk factors contribute
to the development of ADHD [8]. Maternal smoking
during pregnancy has been consistently associated with
an increased risk of ADHD in the offspring [9, 10]. Re-
cent epidemiological studies, however, suggest that the
association between maternal smoking during pregnancy
and ADHD may be largely attributable to familial
confounders, such as genetic traits and social factors
[11, 12]. The possibility of the teratogenic effects of
smoking as a cause of ADHD should be considered, be-
cause some animal models suggest in utero nicotine ex-
posure to be associated with neuronal cell death [13].
Smoking during pregnancy has been represented to as-
sociate with gestational hypoxia [14] and gestational
hypoxia has been suggested to contribute to ADHD-like
symptoms [15]. Maternal smoking during pregnancy has
also been associated with increased offspring risk for
several psychiatric conditions, such as pervasive develop-
mental disorders [16], conduct disorders [17] and de-
pression [18].
Psychiatric comorbidity complicates the assessment of
ADHD [19] and might cause increasing occupational
and educational disability [20]. There are few studies
that have examined the association between maternal
smoking during pregnancy and ADHD associated with
psychiatric comorbidity, focusing mainly on conduct dis-
orders. The results of a cross-sectional Australian study
indicated that maternal smoking during pregnancy dou-
bled the ADHD subjects’ risk of being diagnosed with
oppositional defiant behavior (ODD). The study was
based on parental questionnaires and thus, recall bias
may have contributed to the association [21]. A Norwe-
gian study showed that smoking during pregnancy pre-
dicted increased risk for comorbid ADHD and ODD
[22]. However, those findings were limited by the lack of
adjustment for parental psychiatric history. Given evi-
dence showing an increasing burden of psychiatric dis-
eases among smokers in more recent decades [23], the
potential for confounding by this covariate could be
especially problematic. In this study, we examined
whether maternal smoking during pregnancy is associ-
ated with varying risk among ADHD cases with different
comorbid neuropsychiatric conditions, adjusting for
parental psychiatric history and other potential con-
founders. Specifically, we tested the hypothesis that pre-
natal smoking exposure has a greater risk among ADHD
cases with comorbid psychiatric diagnoses than cases
without comorbidity. We hypothesized that comorbid
ADHD and CD/ODD shows the strongest association
with prenatal exposure to smoking among ADHD with all
co-morbid conditions. The hypotheses were based on pre-
vious study findings showing that gestational smoking ex-
posure is associated with overall psychiatric morbidity.
Methods
This is a nationwide register study based on a nested
case–control design. The sampling frame included all 900
603 liveborn children in Finland between January 1, 1991
and December 31, 2005. We utilized data from record
linkages of three national registers: the Finnish Hospital
Discharge Register (FHDR), Finnish Medical Birth Regis-
ter (FMBR) and Finnish Central Population Register. The
cases and controls were identified from the FHDR and the
Finnish Central Population Register, respectively. Linkage
was achieved by personal identity codes (PIC), which are
assigned to all Finnish citizens and residents by the
Central Population Register since 1971.
National register information
The FMBR, founded in 1987 contains standardized data
on the perinatal period for all live births, and stillbirths
with birth weight of at least 500 g or gestational age of
at least 22 weeks in Finland. The FHDR includes med-
ical diagnoses made in the Finnish public health care
system. The register covers all inpatient wards, in
both somatic and psychiatric hospitals, local health
centres, military wards, prison hospitals, and private
hospitals. Since 1998, it has also covered outpatient
care in public specialized hospitals. In Finland, diag-
nostic classification is based on the International
Classification of Diseases (ICD); ICD-8 (WHO 1967)
from 1969 to 1986, ICD-9 (WHO 1977) from 1987 to
1995 and ICD-10 (WHO 1992) from 1996 onwards.
This register was used in order to identify cases of
ADHD and of co-morbid conditions and parental psy-
chiatric history. The Finnish Central Population
Register is a digital national archive containing basic
information on Finnish citizens and permanent resi-
dents. It is maintained by the Population Register
Centre and local register offices. Individual data re-
corded in the system includes name, personal identity
code (PIC), address, citizenship, native language,
family relations, date of birth, date of death, emigra-
tion/immigration, and other information. The linkage
between the registers was made using the PIC, which
is unchanged throughout the lifespan.
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Study subjects
The cases consisted of all Finnish singletons (citizens or
permanent residents) born between January 1, 1991 and
December 31, 2005 and who were diagnosed with ADHD
(ICD-10: F90.X or ICD-9: 314.X) by December 31, 2011
while treated in Finnish public special health care after the
age of 2 years. Among 10,409 total cases, information on
maternal smoking during pregnancy was available for
10,132, which represent the cases for this study.
For every case, we identified four controls matched by
sex, date of birth (+/- 30 days) and place of birth, exclud-
ing any diagnosis of ADHD or conduct disorders resulting
in 40,141 subjects. Among them, maternal smoking status
during pregnancy was available on 38,811 subjects who
were eventually included in this study. Study subjects with
severe or profound mental retardation were excluded
from both the case and control groups because it is diffi-
cult to assess the symptoms of attentional and hyperkin-
etic disorders among these subjects. The controls with
CD/ODD were not included in the dataset because the
clinical features of CD/ODD and ADHD overlap and these
disorders are difficult to differentiate from one another
[24]. The case and control identifications were based on
hospital diagnoses, and structured diagnostic interviews
were not conducted to fully confirm whether the control
group is entirely free of ADHD. In order to reduce this pos-
sibility, these controls were not included. The cases were
identified from the FHDR and the controls were identified
from the Finnish Central Population Register according to
above-named criteria.
Maternal smoking during pregnancy
Information on maternal smoking during pregnancy was
obtained from the FMBR. These were ascertained by
maternity clinic nurses during routine prenatal visits
during the second trimester of pregnancy and docu-
mented in health records. Maternal smoking during
pregnancy was classified as: non-smokers, smoking only
during the first trimester and smoking after first
trimester.
Covariates
The covariates used in the analyses were: maternal and
paternal psychiatric history, maternal history of any sub-
stance use, maternal and paternal age at birth of off-
spring, maternal and paternal immigrant status,
maternal socioeconomic status (SES), birth weight for
gestational age, Apgar scores at 1 min, number of previ-
ous births and gestational age. Covariates were classified
as represented in Tables 1 and 2. Data on maternal and
paternal age and immigrant status were obtained from
the Finnish Central Population Register. Maternal SES,
maternal marital status, birth weight for gestational age,
Apgar scores at 1 min and gestational age were obtained
from the FMBR.
A father was defined as having a “psychiatric history”
if he had been diagnosed with any mental health dis-
order based on the classification of ICD-8 from year
1969 to 1986 (291-308), ICD-9 from year 1987 to 1995
(291-316) or ICD-10 from year 1996 onwards (F10-99,
excluding mental retardation F70-79). Maternal psycho-
pathology was defined correspondingly with the excep-
tion of separating “history of substance use history” and
“any other psychiatric history” as independent covariates.
These were separated because maternal diagnosis of sub-
stance use might be an indicator of teratogenic risk factors
and thus it differs from paternal substance use diagnosis
and other maternal diagnoses. A mother was defined as
having a “history of substance use disorder” if she had
been diagnosed accordingly based on the classification of
ICD-8 from year 1969 to 1986 (291, 303, 304), ICD-9 from
year 1987 to 1995 (291, 292, 303,304,305) or ICD-10 from
year 1996 onwards (F10-19). Data on parental psychiatric
diagnoses were obtained from the FHDR.
Psychiatric Comorbidity
The lifetime comorbid psychiatric diagnoses of the
subjects were obtained from the FHDR according to
ICD-10 (F10-F99) similar to that used in the case identi-
fication 2011. Only those psychiatric conditions with on-
set typically during early childhood and with high rates
of comorbidity with ADHD were included in the study.
These conditions were mental retardation (F70–F79),
pervasive developmental disorders, including autism
spectrum disorders (ASD) (F84); Tourette syndrome
(F95.2); conduct disorders, including oppositional defi-
ant disorder (CD/ODD) (F90.1, F91, F92) and learning
and coordination disorders (F80–F83). The correspond-
ing comorbid psychiatric conditions were classified into
five groups.
Seventy-six percent of the ADHD cases had at least one
comorbid diagnosis. Learning and coordination disorder
was the most common comorbid diagnostic group
(48.1%). The other most common comorbid diagnoses
were: CD/ODD (28.1%), anxiety disorders (13.6%), aut-
ism spectrum disorders (11.9%), depression (8.9%,) and
mental retardation (3.7%). The psychiatric comorbid
patterns of the sample have been reported recently in
more detail [25]. These findings were in general consist-
ent with previous studies [5]. The overlap between the
observed comorbidities is shown in Additional file 1:
Table S1.
Because these comorbidities showed significant overlap
each case was assigned to only one comorbid group in a
hierarchical manner in the following order: first mental
retardation; second ASD; third Tourette syndrome; fourth
CD/ODD and fifth learning and coordination disorders.
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For example, if a case was diagnosed with both mild
mental retardation and Tourette syndrome, she/he
would be assigned to the group of mental retardation. If
the case had none of the previous conditions, he/she
would be classified into group six, “ADHD without co-
morbidities”. As listed in Table 4, the hierarchy was
based on the chronicity, severity and impairment of
functional abilities in each disorder. For example, mental
retardation and autism are consistently severe and life-
long conditions which impair daily activities.
Statistical analyses
Multivariable analyses were conducted initially to test
the significance of association between covariates and
Table 1 Potential confounding factors in relation to maternal smoking during pregnancy in controls





Maternal age at birth ≤19 years 529 (1.7 %) 48 (7.9 %) 322 (6.4 %) p < 0.001 647.55
20–29 years 15,660 (50.1 %) 365 (59.8 %) 2836 (56.2 %)
30–39 years 14,195 (45.4 %) 186 (30.5 %) 1762 (34.9 %)
≥40 years 886 (2.8 %) 11 (1.8 %) 123 (2.4 %)
Paternal age at birtha ≤19 years 106 (0.3 %) 11 (1.9 %) 95 (1.9 %) p < 0.001 413.72
20–29 years 11,414 (36.8 %) 297 (49.9 %) 2255 (45.9 %)
30–39 years 16,485 (53.1 %) 247 (41.5 %) 2160 (44.0 %)
≥40 years 3052 (9.8 %) 40 (6.7 %) 404 (8.2 %)
History of maternal
psychopathology
Yes 3321 (10.6 %) 92 (15.1 %) 927 (18.4 %) p < 0.001 258.83
No 27,949 (89.4 %) 518 (84.9 %) 4116 (81.6 %)
History of maternal
substance abuse
Yes 357 (1.1 %) 22 (3.6 %) 368 (7.3 %) p < 0.001 837.97
No 30,913 (98.9 %) 588 (96.4 %) 4675 (92.7 %)
History of paternal
psychopathologya
Yes 3387 (10.9 %) 109 (18.3 %) 1101 (22.4 %) p < 0.001 528.64
No 27,670 (89.1 %) 486 (81.7 %) 3813 (77.6 %)
Previous births 0 12,557 (40.2 %) 381 (62.5 %) 2139 (42.4 %) p < 0.001 129.23
≥1 18,713 (59.8 %) 229 (37.5 %) 2904 (57.6 %)
Weight for gestational
ageb
<-2 SD 716 (2.3 %) 16 (2.6 %) 285 (5.7 %) p < 0.001 219.66
-2 to +2 SD 29,330 (94.1 %) 571 (93.9 %) 4641 (92.4 %)
≥ + 2 SD 1141 (3.7 %) 21 (3.5 %) 95 (1.9 %)
Maternal SES Upper white collar 5325 (17.0 %) 40 (6.6 %) 263 (5.2 %) p < 0.001 1179.59
Lower white collar 14,404 (46.1 %) 234 (38.4 %) 1890 (37.5 %)
Blue collar 4809 (15.4 %) 161 (26.4 %) 1552 (30.8 %)
Others 4663 (14.9 %) 129 (21.2 %) 901 (17.9 %)
Missing 2069 (6.6 %) 46 (7.5 %) 437 (8.7 %)
Maternal immigrant
status
Not born in Finland 491 (1.6 %) 13 (2.1 %) 38 (0.8 %) p < 0.001 21.91
Born in Finland 30,779 (98.4 %) 597 (97.9 %) 5005 (99.2 %
Paternal immigrant
statusa
Not born in Finland 557 (1.8 %) 9 (1.5 %) 85 (1.7 %) p < 0.841 0.35
Born in Finland 30,500 (98.2 %) 586 (98.5 %) 4829 (98.3 %)
Apgar score at 1 minc <6 1151 (3.7 %) 30 (4.9 %) 195 (3.9 %) p < 0.229 2.95
7–10 30,086 (96.3 %) 577 (95.1 %) 4841 (96.1 %)
Gestational aged ≤32 weeks 195 (0.6%) 3 (0.5%) 47 (1.0%) p < 0.029 14.11
33–36 weeks 1171 (3.8%) 19 (3.1%) 218 (4.3%)
37–41 weeks 28,407 (91.0%) 553 (90.8%) 4546 (90.5%)
≥42 weeks 1431 (4.6%) 34 (5.6%) 212 (4.2%)
adata missing: 357 subjects
bdata missing: 145 subjects
cdata missing 43 subjects
ddata missing 87 subjects
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maternal smoking among controls as well as between
covariates and ADHD diagnosis using Pearson’s χ2 -test.
The primary outcome variable was an ADHD diagnosis
(no/yes). Conditional logistic regression models were
used to examine the association between maternal
smoking and ADHD with odds ratios (OR) and 95 %
confidence intervals (CI).
The unadjusted model was used to evaluate the as-
sociation between maternal smoking and the outcome
in the entire sample. Maternal smoking was classified
first as a dichotomous variable and then as a categor-
ical variable by timing during gestation (no smoking
/during first trimester only/after first trimester). The
multivariable logistic regression model was used to
evaluate the associations adjusting for covariates. In
this comparison the reference group were the
controls. Statistical significance (2-tailed) was judged
at p <0.05.
Table 2 Potential confounding factors in relation to case-control status
Cases Controls p χ2
Maternal age at birth ≤19 years 672 (6.7 %) 899 (2.4 %) p < 0.001 603.69
20–29 years 5711 (56.5 %) 18,861 (51.1 %)
30–39 years 3475 (34.4 %) 16,143 (43.7 %)
≥40 years 254 (2.5 %) 1020 (2.8 %)
Paternal age at birtha ≤19 years 211 (2.2 %) 212 (0.6 %) p < 0.001 330.41
20–29 years 4322 (44.2 %) 13,966 (38.2 %)
30–39 years 4358 (44.5 %) 18,892 (51.7 %)
≥40 years 896 (9.2 %) 3496 (9.6 %)
History of maternal
psychopathology
Yes 2610 (25.8 %) 4340 (11.8 %) p < 0.001 1154.75
No 7502 (74.2 %) 32,583 (88.3 %)
History of maternal
substance abuse
Yes 685 (6.8 %) 747 (2.0 %) p < 0.001 525.72
No 9427 (93.2 %) 36,176 (98.0 %)
History of paternal
psychopathologya
Yes 2382 (24.3 %) 4597 (12.6 %) p < 0.001 779.19
No 7405 (75.7 %) 31,969 (87.4 %)
Previous births 0 4683 (46.3 %) 15,077 (40.8 %) p < 0.001 98.03
≥1 5429 (53.7 %) 21,846 (59.2 %)
Weight for gestational
ageb
<-2 SD 569 (5.6 %) 1017 (2.8 %) p < 0.001 189.09
-2 to +2 SD 9167 (91.0 %) 34,542 (93.8 %)
≥ + 2 SD 338 (3.4 %) 1257 (3.4 %)
Maternal SES Upper white collar 861 (8.5 %) 5628 (17.7 %) p < 0.001 593.56
Lower white collar 3986 (39.4 %) 6522 (15.2 %)
Blue collar 2439 (24.1 %) 16,528 (44.8 %)
Others 1959 (19.4 %) 5693 (15.4 %)
Missing 867 (8.6 %) 2552 (6.9 %)
Maternal immigrant
status
Not born in Finland 223 (2.2 %) 542 (1.5 %) p < 0.001 26.04
Born in Finland 9889 (97.8 %) 36,381 (98.5 %)
Paternal immigrant
statusa
Not born in Finland 368 (3.8 %) 651 (1.8 %) p < 0.001 136.41
Born in Finland 9419 (96.2 %) 35,915 (98.2 %)
Apgar score at 1 minc <6 537 (5.3 %) 1376 (3.7 %) p < 0.001 48.65
7–10 9565 (94.7 %) 35,504 (96.3 %)
Gestational age ≤32 weeks 224 (2.2%) 245 (0.7%) p < 0.001 219.24
33–36 weeks 564 (5.6%) 1408 (3.8%)
37–41 weeks 8833 (87.6%) 33,506 (91.0%)
≥42 weeks 460 (4.6%) 1677 (4.5%)
adata missing 682 subjects
bdata missing: 107 subjects
cdata missing 53 subjects
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Subsequently, we compared the relationships between
maternal smoking and odds for ADHD alone and with
each comorbid condition. Finally, we compared the
relationships between maternal smoking and each
ADHD-comorbid group with the “ADHD without co-
morbidities”. In the multivariable regression model
adjustment was made for covariates with associations
between both smoking and the outcome covariates at
p < 0.1. The interaction term between ADHD with
each comorbidity versus “ADHD without comorbidity”
was assessed to compare the magnitude of ORs for
smoking during pregnancy. In addition, differences in
the magnitude of the ORs for ADHD between smok-
ing only during the first trimester and smoking after
the first trimester were tested correspondingly.
Statistical analyses were performed with SAS statistical
software [26].
Results
Among the potential covariates, maternal and paternal
psychiatric history, maternal substance abuse history,
maternal and paternal age at birth, maternal socioeco-
nomic status, weight for gestational age, number of
previous births and gestational age were associated with
both maternal smoking during pregnancy among the
controls and ADHD and were included as covariates in
the analyses (Tables 1 and 2). Weight for gestational age
and gestational age were not included simultaneously as
covariates in analyses because of their potential
multicollinearity.
As shown in Table 3, 30.3 % of the mothers of cases
smoked during pregnancy, whereas the corresponding
figure was 15.3 % for the mothers of controls. The odds
for ADHD in the entire sample was significantly in-
creased among subjects exposed to maternal smoking
during pregnancy when adjusted for confounders (OR
1.73, 95 % CI: 1.62–1.84, p < 0.001). Among the cases,
2.2 % of mothers smoked only during the first trimester
and 28.1 % after the first trimester. Among controls, the
corresponding figures were 1.6 % and 13.7 %. There
were increased odds for ADHD associated with maternal
smoking after first trimester (adjusted OR 1.79, 95 % CI:
1.68–1.92, p < 0.001) as well as smoking only during the
first trimester (OR 1.24, 95 % CI: 1.03–1.50, p < 0.012).
There were significant differences in the magnitude of the
odds for ADHD between smoking only during the first tri-
mester and smoking after first trimester (p < 0.001). The
difference in odds for ADHD between smoking during
pregnancy and during the first trimester only was statisti-
cally significant (p < 0.001).
The associations between maternal smoking during
pregnancy and odds of ADHD with each comorbid con-
dition are shown in the Table 4. Smoking during preg-
nancy was examined as a binary variable (yes/no)
instead of considering specific periods because the num-
ber of subjects exposed to smoking only during the first
trimester was not sufficient for statistical analysis in each
diagnostic group. Smoking during pregnancy was a risk
factor for ADHD with each comorbid disorder. The high-
est risk was seen with comorbid CD/ODD (OR = 2.54
95 % CI 2.24–2.88, p < 0.001) and the lowest with learning
disorders (OR = 1.51 95 % CI 1.35–1.68, p < 0.001). In
addition with other confounders the results were ad-
justed first with weight for gestational age (ADHD
without comorbidities OR 1.59, 95% CI 1.43–1.77), second
with gestational age (OR 1.61 95% CI 1.45–1.78) and
third with neither (OR 1.61, 95% CI 1.45–1.79). The
results were similar in all three models for all comorbid
categories.
As shown in Table 5, comparing each ADHD-
comorbid group with the “ADHD without comorbidi-
ties” the comorbid CD/ODD was the only diagnostic
group which had a significantly stronger association
with smoking (adjusted OR 1.80 95 % CI 1.55–2.11,
p < 0.001). The association between smoking and co-
morbid CD/ODD was significantly stronger compared
to the respective associations for each of the other
ADHD-comorbid diagnostic groups in unadjusted
models. In the adjusted model only the groups of
ADHD subjects with comorbid Tourette syndrome
and mental retardation did not differ significantly
from the group with ADHD and CD/ODD.
Discussion
The present study has several findings which add to the
evidence of a complex association between exposure to
Table 3 Associations between ADHD and maternal smoking during pregnancy
Frequencies OR (95 % CI)
Maternal smoking status Cases n (%) Controls n (%) Unadjusted Adjusteda
Not smoking during pregnancy 7068 (69.7 %) 33,158 (84.7 %) Reference Reference
Smoking during pregnancy (Yes/No) 3064 (30.3 %) 5653 (15.3 %) 2.44 (2.32–2.58) 1.75 (1.65–1.86)
Smoking after first trimester 2839 (28.1 %) 5043 (13.7 %) 2.54 (2.41–2.68) 1.81 (1.71–1.93)
Smoking only during first trimester 225 (2.2 %) 610 (1.7 %) 1.66 (1.41–1.94) 1.25 (1.05–1.48)
OR odds ratio, CI confidence interval
aAdjusted for maternal and paternal psychiatric history, maternal substance use history, maternal and paternal age at birth, maternal socioeconomic status, birth
weight for gestational age, number of previous births and maternal marital status
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smoking during pregnancy and later ADHD with comor-
bid conditions. First, prenatal smoking exposure was as-
sociated with increased risk of ADHD with comorbid
neuropsychiatric disorders. Second, comparing each of
the co-morbid groups with the control group, the stron-
gest association was found with ADHD comorbid with
CD/ODD. Third, the group with ADHD and CD/ODD
was the only group showing a statistically significant as-
sociation with smoking compared to the group of
ADHD without comorbidities. To our knowledge, this is
the first study to report these associations in a large
nationwide sample.
The association between maternal smoking during
pregnancy and, offspring ADHD and, specifically CD/
ODD status has several possible explanations. First, ex-
posure to smoking during pregnancy might have direct
intrauterine effects mediated by nicotine contributing to
risk for ADHD and CD/ODD. Nicotine has been shown
to transfer across the placenta to the fetus [27]. Also,
nicotine is an agonist of acetylcholine and can in this
way interfere with fetal central nervous system
maturation. [28]. In animal models nicotine exposure is
associated with increased locomotor activity which is
considered as an indicator for ADHD [29]. Furthermore,
nicotine exposure during pregnancy has been argued to
increase risk for later conduct problems [30]. Second,
the association of smoking and CD/ODD and ADHD
might partially be explained by gene-environment-
interaction. Early smoking exposure might increase the
risk of comorbid ADHD and CD/ODD particularly
among children with a specific genetic vulnerability. For
example, children exposed to maternal smoking during
pregnancy were given higher hyperactive-impulsive and
oppositional scores if they were homozygous for the 10-
repeat dopamine transporter gene allele [31]. Third,
smoking might be a proxy for risk factors leading to
ADHD and CD/ODD with independent mechanisms.
The overall tendency to smoke cigarettes correlates with
the level of ADHD symptoms [32]. It is possible that
among smoking mothers, a significant proportion have
sub-clinical ADHD which are not diagnosed in health-
care services and are thus unidentified. Therefore, smok-
ing exposure might be an indicator of genetic risk
factors. Simultaneously, smoking is also associated with
harsh parenting practices [33] which are associated with
disruptive behavior of the offspring [34]. Furthermore,
poor parenting skills have been suggested to increase the
risk of comorbid psychiatric conditions among children
with ADHD who might be especially vulnerable to harsh
or non-supportive parenting styles [35].
The association between prenatal smoking exposure
and offspring ADHD in general was in line with previous
similar studies reporting findings of ORs ranging
between 1.5 and 2.4 [9, 10]. The differences of the odds
between smoking only during the first trimester and
after the first trimester suggest a possibility of a dose-
response effect. This hypothesis is supported by a previ-
ous finding of a linear correlation between number of
cigarettes smoked during pregnancy and severity of at-
tentional problems [36]. The dose-response-effect could
Table 4 Associations between ADHD and maternal smoking during pregnancy among comorbid neuropsychiatric conditions
Cases exposed to smoking
during pregnancy n (%)
Controls exposed to smoking
during pregnancy n (%)
OR (95 % CI)
Unadjusted
OR (95 % CI)
Adjusteda
ADHD +Mental Retardation (N = 374) 106 (28.3 %) 173 (12.6 %) 2.79 (2.10–3.72) 1.93 (1.38–2.69)
ADHD + ASD (n = 1134) 299 (26.4 %) 593 (14.3 %) 2.14 (1.82–2.51) 1.59 (1.33–1.91)
ADHD + Tourette (n = 172) 45 (26.2 %) 89 (14.3 %) 2.06 (1.36–3.13) 1.74 (1.06–2.86)
ADHD + CD/ODD (n = 2339) 950 (40.6 %) 1308 (15.4 %) 3.96 (3.55–4.41) 2.54 (2.24–2.88)b
ADHD + Learning and coordination
disorders (n = 2957)
799 (27.0 %) 1726 (16.0 %) 1.98 (1.80–2.19) 1.51 (1.35–1.68)
ADHD without comorbidities (n = 3136) 865 (27.6 %) 1764 (15.4 %) 2.11 (1.92–2.32) 1.59 (1.43–1.77)
Reference category in each group were their designated controls
OR odds ratio, CI confidence interval
aAdjusted for:maternal and paternal psychiatric history, maternal substance abuse history, maternal and paternal age at birth, maternal socioeconomic status, birth
weight for gestational age, number of previous births and maternal marital status
bOR was significantly different from “ADHD without comorbidities”, p < 0.001
Table 5 The comparisons of associations between maternal
smoking and groups with ADHD and comorbid conditions and







1.32 (0.98–1.79) 1.32 (0.96–1.83)
ADHD + ASD (n = 1134) 1.01 (0.84–1.22) 0.98 (0.80–1.20)
ADHD + Tourette (n = 172) 0.98 (0.64–1.50) 1.06 (0.67–1.68)
ADHD + CD/ODD (n = 2339) 1.87 (1.62–2.16) 1.80 (1.55–2.11)
ADHD + Learning and
coordination disorders (n = 2957)




OR odds ratio, CI confidence interval
aAdjusted for: maternal and paternal psychiatric history, maternal substance
abuse history, maternal and paternal age at birth, maternal socioeconomic
status, birth weight for gestational age and number of previous births
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be mediated by chronic hypoxia to the fetal brain as ani-
mal models have demonstrated association between neo-
natal hypoxia and ADHD-like behavior [15]. The fetal
brain could also be more vulnerable to smoking expos-
ure in the later periods of pregnancy. Alternatively, the
ability to quit smoking after the first trimester might be
a proxy for unknown protective maternal attributes. As
shown in the Table 1, the mothers who smoked after the
first trimester had more often a history of psychiatric
disorders compared to mothers who ceased smoking. It
is unclear whether, for example, bipolar disorder or
schizophrenia are more common within mothers smok-
ing after the first trimester, especially given that these
parental disorders have been associated with offspring
ADHD [37].
The present study is based on a large nationwide
sample, and the analyses were adjusted with several con-
founders. However, there are limitations that need to be
considered while interpreting the findings. First, the sub-
jects include only the ADHD cases referred to special-
ized mental health services and assumingly these
represent mainly the patients with the most severe
symptoms of ADHD. The healthcare services in Finland
are universal and publicly funded; children are exempted
from the generally low patient fees. Because of this the
number of severe ADHD cases missing due to lack of
access to health services is expected to be small. Second,
the maternal smoking status was based on a self-report.
Previous studies have shown that pregnant mothers
under-report their smoking. Actually, between 7 and
22 % of the self-reported non-smokers were smokers ac-
cording to the blood and urine cotinine levels [38, 39].
Third, there are several potential confounders not avail-
able in this study, e.g. paternal smoking, and prenatal
alcohol and drug exposure. However, information about
maternal substance use diagnosis was included in the
analyses. Fourth, we did not have information on chil-
dren diagnosed only with CD/ODD. Therefore, we are
not able to address the question whether the association
between smoking and ADHD and CD/ODD could be
due to the effects of smoking on CD/ODD independent
of ADHD. Indeed, there is evidence of the association
between smoking exposure and conduct problems [17].
However, few previous studies have not shown maternal
smoking to have an effect on conduct problems when
the results have been adjusted with parental psychiatric
history and socioeconomic factors [40, 41]. Fifth, con-
trols with CD/ODD were excluded which could
strengthen the association between smoking and ADHD
comorbid with CD/ODD compared to other diagnostic
groups. However, the cumulative incidence of CD/ODD
diagnosis in Finland by the age of 14 has recently been
reported to be only 1.4 % [42] and, thus, the exclusion is
expected to have a modest influence to the results at the
most. Furthermore, the association between smoking
and ADHD with comorbid CD/ODD was significantly
stronger compared to the group without comorbidities.
This indicates that our findings cannot be explained only
by the exclusion of controls with a CD/ODD diagnosis.
Sixth, common internalizing disorders, such as anxiety
and depression, were not included in the analysis. Anx-
iety and depression may have onset at adolescence or
adulthood whereas the included disorders typically have
an onset at childhood. Including these disorders in the
utilized hierarchical model would have been compli-
cated. However, exclusion of internalizing comorbidities
is not expected to affect the conclusions drawn from our
results.
Conclusions
The study supports previous findings of association be-
tween smoking during pregnancy and offspring ADHD.
In future studies utilization of biological markers of
smoking such as cotinine levels would confirm the
present results. The children with the combination of
ADHD and CD/ODD show more tendency to develop
mood disorders [43] and later criminal activity [44] com-
pared to children with ADHD only. The strong associ-
ation between prenatal smoking exposure and comorbid
CD/ODD and ADHD warrants further research consid-
ering the higher risk among these subjects of an overall
poor health outcome compared to only ADHD. Future
studies on ADHD and CD/ODD should examine the as-
sociation between smoking and these disorders as both
independent and comorbid conditions. Our findings add
to the mounting evidence that smoking during preg-
nancy has an adverse effect on the developing fetal brain
and is associated with the development of neurodevelop-
mental disorders. Finally, regardless of the precise patho-
genic mechanisms, prenatal smoking represents an
important risk factor for the ADHD comorbid with CD.
Additional file
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